Rumor on has it that there have been negotiations in the mid 20's area, which Zakrzewski apparently did not accept. If the price is upped to the 30's there might be a buyout. This might explain the CEO's message this morning. Does anyone have confirmation of the rumors?
While some people were taunting me for buying 7000 shares this morning at 14.25 (who's laughing now?)... I sure hope there will be a buyout at 30. But I'm a long term investor and don't expect to get rich quick. I will welcome it though! :-)
No confirmation of a rumor only my following opinion:
This was a way for Zakrzewski to communicate to the market where a bid needs to be in order to make it happen. It's very apparent that the CEO was telegraphing the range that would be acceptable. I'm sure during his private discussions $30+ came up as a short term buy out valuation, however, $100 has also likely been brought up as a longer term buy out valuation.
Buy AMRN now for $30+ or wait for FDA approval and pay ~$100.